{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T18:37:23Z","timestamp":1793299043427,"version":"4.5.0"},"reference-count":49,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,11]]},"DOI":"10.1097\/icu.0b013e3282f0b4a9","type":"journal-article","created":{"date-parts":[[2007,10,12]],"date-time":"2007-10-12T03:01:31Z","timestamp":1192158091000},"page":"443-449","source":"Crossref","is-referenced-by-count":10,"title":["Giant cell arteritis"],"prefix":"10.1097","volume":"18","author":[{"given":"Helen V","family":"Danesh-Meyer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J","family":"Savino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-2-20210206","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/art.1780380311","article-title":"Epidemiology of polymyalgia rheumatica in Olmsted County, Minnesota 1970\u20131991","volume":"38","author":"Salvarani","year":"1995","journal-title":"Arthritis Rheum"},{"key":"R2-2-20210206","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1002\/1529-0131(199805)41:5<778::AID-ART4>3.0.CO;2-V","article-title":"Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States","volume":"41","author":"Lawrence","year":"1998","journal-title":"Arthritis Rheum"},{"key":"R3-2-20210206","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/S0161-6420(01)00574-7","article-title":"The epidemiology of giant cell arteritis: a 12-year retrospective study","volume":"108","author":"Liu","year":"2001","journal-title":"Ophthalmology"},{"key":"R4-2-20210206","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ajo.2006.07.048","article-title":"Giant cell arteritis among Hispanic Americans","volume":"143","author":"Lam","year":"2007","journal-title":"Am J Ophthalmol"},{"key":"R5-2-20210206","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S0889-857X(05)70232-5","article-title":"Epidemiology of the vasculitides","volume":"27","author":"Gonzalez-Gay","year":"2001","journal-title":"Rheum Dis Clin North Am"},{"key":"R6-2-20210206","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.jvs.2005.12.043","article-title":"Giant-cell temporal arteritis in a 17-year-old male","volume":"43","author":"Pipinos","year":"2006","journal-title":"J Vasc Surg"},{"key":"R7-2-20210206","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/0002-9394(70)91859-3","article-title":"Histopathology of ischaemic optic neuropathy","volume":"69","author":"Henkind","year":"1970","journal-title":"Am J Ophthalmol"},{"key":"R8-2-20210206","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S0161-6420(00)00602-3","article-title":"The prevalence of cupping in end-stage arteritic and nonarteritic anterior ischemic optic neuropathy","volume":"108","author":"Danesh-Meyer","year":"2001","journal-title":"Ophthalmology"},{"key":"R9-2-20210206","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.ophtha.2004.12.041","article-title":"Comparison of arteritis and nonarteritic anterior ischemic optic neuropathies with the Heidelberg retina tomography","volume":"112","author":"Danesh-Meyer","year":"2005","journal-title":"Ophthalmology"},{"key":"R10-2-20210206","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S0002-9394(14)72073-2","article-title":"Branch retinal artery occlusion as the initial sign of giant cell arteritis","volume":"122","author":"Fineman","year":"1996","journal-title":"Am J Ophthalmol"},{"key":"R11-2-20210206","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.ophtha.2005.01.031","article-title":"Management of the patient with suspected temporal arteritis: a decision-analytic approach","volume":"112","author":"Niederkohr","year":"2005","journal-title":"Ophthalmology"},{"key":"R12-2-20210206","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1136\/bmj.286.6361.266","article-title":"Simple rule for calculating normal erythrocyte sedimentation rate","volume":"286","author":"Miller","year":"1983","journal-title":"Br Med J"},{"key":"R13-2-20210206","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1001\/archopht.1987.01060070101037","article-title":"Erythrocyte sedimentation rate and its relationship to hematocrit in giant cell arteritis","volume":"105","author":"Jacobson","year":"1987","journal-title":"Arch Ophthalmol"},{"key":"R14-2-20210206","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1016\/j.ophtha.2006.05.020","article-title":"Prevalence of a normal C-reactive protein with an elevated erythrocyte sedimentation rate in biopsy-proven giant cell arteritis","volume":"113","author":"Parikh","year":"2006","journal-title":"Ophthalmology"},{"key":"R15-2-20210206","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/00041327-200020020-00001","article-title":"Thrombocytosis in temporal arteritis. Rising platelet counts: a red flag for giant cell arteritis","volume":"20","author":"Lincoff","year":"2000","journal-title":"J Neuroophthalmol"},{"key":"R16-2-20210206","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/S0161-6420(02)01076-X","article-title":"Thrombocytosis in patients with biopsy-proven giant cell arteritis","volume":"109","author":"Foroozan","year":"2002","journal-title":"Ophthalmology"},{"key":"R17-2-20210206","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1167\/iovs.06-1106","article-title":"A Bayesian analysis of the true sensitivity of a temporal artery biopsy","volume":"48","author":"Niederkohr","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R18-2-20210206","first-page":"1216","article-title":"Shrinkage: fact or fiction?","volume":"119","author":"Danesh-Meyer","year":"2001","journal-title":"Arch Ophthalmol"},{"key":"R19-2-20210206","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/S0008-4182(06)80016-5","article-title":"Quantitative analysis of temporal artery contraction after biopsy for evaluation of giant cell arteritis","volume":"41","author":"Su","year":"2006","journal-title":"Can J Ophthalmol"},{"key":"R20-2-20210206","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/00041327-200020030-00011","article-title":"Low diagnostic yield with second biopsies in giant cell arteritis","volume":"20","author":"Danesh-Meyer","year":"2000","journal-title":"J Neuroophthalmol"},{"key":"R21-2-20210206","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1136\/bjo.2006.101725","article-title":"Histological parameters helpful in recognizing steroid-treated temporal arteritis: an analysis of 35 cases","volume":"91","author":"Font","year":"2007","journal-title":"Br J Ophthalmol"},{"key":"R22-2-20210206","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S0161-6420(02)01775-X","article-title":"Recovery of visual function in patients with biopsy-proven giant cell arteritis","volume":"110","author":"Foroozan","year":"2003","journal-title":"Ophthalmology"},{"key":"R23-2-20210206","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.ophtha.2005.01.036","article-title":"Poor prognosis of visual outcome after visual loss from giant cell arteritis","volume":"112","author":"Danesh-Meyer","year":"2005","journal-title":"Ophthalmology"},{"key":"R24-2-20210206","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1034\/j.1600-0420.2002.800403.x","article-title":"Visual improvement with corticosteroid therapy in giant cell arteritis. Report of a large study and review of the literature","volume":"80","author":"Hayreh","year":"2002","journal-title":"Acta Ophthalmol Scand"},{"issue":"A","key":"R25-2-20210206","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/j.1445-5994.2006.01299.x","article-title":"Amaurosis in patients with giant cell arteritis: treatment with antitumour necrosis factor-\u03b1","volume":"37","author":"Torrente","year":"2007","journal-title":"Int Med J"},{"key":"R26-2-20210206","doi-asserted-by":"crossref","first-page":"631","DOI":"10.7326\/0003-4819-146-9-200705010-00005","article-title":"Infliximab plus prednisone or placebo plus prednisone for the initial treatment of polymyalgia rheumatica","volume":"146","author":"Salvarani","year":"2007","journal-title":"Ann Intern Med"},{"key":"R27-2-20210206","doi-asserted-by":"crossref","first-page":"621","DOI":"10.7326\/0003-4819-146-9-200705010-00004","article-title":"Infliximab for maintenance of glucocorticosteroid-induced remission of giant cell arteritis","volume":"146","author":"Hoffman","year":"2007","journal-title":"Ann Intern Med"},{"key":"R28-2-20210206","first-page":"495","article-title":"A prospective, double blind, randomized, placebo controlled trial of methotrexate in the treatment of giant cell arteritis (GCA)","volume":"19","author":"Spiera","year":"2001","journal-title":"Clin Exp Rheumatol"},{"key":"R29-2-20210206","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1002\/art.10262","article-title":"A multicenter, randomized, double-blind, placebo-controlled trial of adjuvant methotrexate treatment for giant cell arteritis","volume":"5","author":"Hoffman","year":"2002","journal-title":"Arthritis Rheum"},{"key":"R30-2-20210206","doi-asserted-by":"crossref","first-page":"106","DOI":"10.7326\/0003-4819-134-2-200101160-00010","article-title":"Combined treatment of giant cell arteritis with methotrexate and prednisone. A randomized, double-blind, placebo-controlled trial","volume":"134","author":"Jover","year":"2001","journal-title":"Ann Intern Med"},{"key":"R31-2-20210206","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/art.10071","article-title":"Therapeutic effects of acetylsalicylic acid in giant cell arteritis","volume":"46","author":"Weyand","year":"2002","journal-title":"Arthritis Rheum"},{"key":"R32-2-20210206","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.1002\/art.22141","article-title":"Antiplatelet and anticoagulant therapy in patients with giant cell arthritis","volume":"54","author":"Lee","year":"2006","journal-title":"Arthritis Rheum"},{"key":"R33-2-20210206","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1002\/art.20171","article-title":"Low-dose aspirin and prevention of cranial ischemic complications in giant cell arteritis","volume":"50","author":"Nesher","year":"2004","journal-title":"Arthritis Rheum"},{"key":"R34-2-20210206","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/S0161-6420(03)00228-8","article-title":"Visual deterioration in giant cell arteritis patients while on high doses of corticosteroid therapy","volume":"110","author":"Hayreh","year":"2003","journal-title":"Ophthalmology"},{"key":"R35-2-20210206","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1001\/jama.1957.02970450023007","article-title":"Treatment of temporal arteritis with adrenal corticosteroids","volume":"163","author":"Birkhead","year":"1957","journal-title":"J Am Med Assoc"},{"key":"R36-2-20210206","first-page":"471","article-title":"Giant cell arteritis","volume":"28","author":"Ross Russell","year":"1959","journal-title":"Q J Med"},{"key":"R37-2-20210206","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1212\/WNL.10.5.490","article-title":"Neurologic aspects of temporal arteritis","volume":"10","author":"Hollenhorst","year":"1960","journal-title":"Neurology"},{"key":"R38-2-20210206","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1136\/bjo.85.9.1061","article-title":"Steroid management in giant cell arteritis","volume":"85","author":"Chan","year":"2001","journal-title":"Br J Ophthalmol"},{"key":"R39-2-20210206","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1016\/S0161-6420(94)31102-X","article-title":"Visual morbidity in giant cell arteritis. Clinical characteristics and prognosis of vision","volume":"101","author":"Liu","year":"1994","journal-title":"Ophthalmology"},{"key":"R40-2-20210206","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1053\/sarh.2001.16650","article-title":"Biopsy-negative giant cell arthritis: clinical spectrum and predictive factors for positive temporal artery biopsy","volume":"30","author":"Gonzalez-Gay","year":"2001","journal-title":"Semin Arthritis Rheum"},{"key":"R41-2-20210206","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/S0755-4982(04)98939-7","article-title":"Is giant cell arteritis an infectious disease? Biological and epidemiological evidence","volume":"33","author":"Duhaut","year":"2004","journal-title":"Presse Med"},{"key":"R42-2-20210206","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S1568-9972(03)00064-8","article-title":"Immunopathways in giant cell arteritis and polymyalgia rheumatica","volume":"3","author":"Weyand","year":"2004","journal-title":"Autoimmun Rev"},{"key":"R43-2-20210206","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1056\/NEJM198107093050216","article-title":"Increased prevalence of HLA-DR4 in giant-cell arteritis","volume":"305","author":"Barrier","year":"1981","journal-title":"N Engl J Med"},{"key":"R44-2-20210206","first-page":"993","article-title":"HLA-DR locus antigens in polymyalgia rheumatica and giant cell arteritis","volume":"8","author":"Calamia","year":"1981","journal-title":"J Rheumatol"},{"key":"R45-2-20210206","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1172\/JCI116125","article-title":"The HLA-DRB1 locus as a genetic component in giant cell arteritis. Mapping of a disease-linked sequence motif to the antigen-binding site of the HLA-DR molecule","volume":"90","author":"Weyand","year":"1992","journal-title":"J Clin Invest"},{"key":"R46-2-20210206","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1002\/1529-0131(200008)43:8<1749::AID-ANR11>3.0.CO;2-K","article-title":"Association of giant cell arteritis and polymalgia rheumatica with different tumor necrosis factor microsatellite polymorphisms","volume":"43","author":"Mattey","year":"2000","journal-title":"Arthritis Rheum"},{"key":"R47-2-20210206","first-page":"675","article-title":"Interleukin-1 cluster and tumor necrosis factor-\u03b1 gene polymorphisms in polymyalgia rheumatica","volume":"18","author":"Boiardi","year":"2000","journal-title":"Clin Exp Rheumatol"},{"key":"R48-2-20210206","first-page":"502","article-title":"Intracellular adhesion molecular 1 polymorphisms in polymyalgia rheumatica\/giant cell arteritis: association with disease risk and severity","volume":"29","author":"Salvarani","year":"2002","journal-title":"J Rheumatol"},{"key":"R49-2-20210206","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/ar293","article-title":"Genetic epidemiology in giant cell arteritis and polymyalgia rheumatica","volume":"3","author":"Gonzalez-Gay","year":"2001","journal-title":"Arthritis Res"}],"container-title":["Current Opinion in Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/ICU.0b013e3282f0b4a9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T16:51:10Z","timestamp":1786035070000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00055735-200711000-00002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,11]]},"references-count":49,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/icu.0b013e3282f0b4a9","relation":{},"ISSN":["1040-8738"],"issn-type":[{"value":"1040-8738","type":"print"}],"subject":[],"published":{"date-parts":[[2007,11]]}}}